Accession Number: | 0001209191-19-059883 |
Date: | 2019-12-09 |
Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Original Submission Date: |
SACHDEV AMIT
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-09 | M | 5,000 | a | $109.14 | 38,416 | direct | ||
COMMON STOCK | 2019-12-09 | S | 5,000 | d | $225.00 | 33,416 | direct | ||
COMMON STOCK | 2019-12-09 | 0 | $0.00 | 882 | indirect | ||||
COMMON STOCK | 2019-12-09 | 0 | $0.00 | 18,964 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 109.14 | 2019-12-09 | deemed execution date | M | 5,000 (d) | 2025-02-02 | common stock 5,000 | $109.14 | 42,500 | direct |
ID | footnote |
---|---|
f1 | transaction made pursuant to mr. sachdev's company approved trading plan under rule 10b5-1. |
f2 | fully vested. |